The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab

Publication date: September 2020Source: Clinical Lymphoma Myeloma and Leukemia, Volume 20, Issue 9Author(s): S. Shahzad Mustafa, Saad Jamshed, Karthik Vadamalai, Allison Ramsey
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research